Nodal evaluation in wilms' tumors: Analysis of the national cancer data base

Annals of Surgery

Volumn 251, Issue 3, 2010, Pages 559-565

  Raval, Mehul V ^a,b,c   Bilimoria, Karl Y ^a,c   Bentrem, David J ^c,d   Stewart, Andrew K ^a   Winchester, David P ^a,e   Ko, Clifford Y ^a,f,g   Reynolds, Marleta ^b  

^a AMERICAN COLLEGE OF SURGEONS   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d JESSE BROWN VA MEDICAL CENTER   (United States)

^e NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; INFANT; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; PROGNOSIS; REGISTRIES; SURVIVAL RATE; UNITED STATES; WILMS TUMOR;

EID: 77649131482     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181cc95d7     Document Type: Article

References (43)

1. Gurney JG, Severson RK, Davis S, et al. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer. 1995;75:2186-2195.
2. Ries LA, Smith MA, Gurney JG, et al. Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995, National Cancer Institute, SEER program. Bethesda, MD: NIH; 1999. Pub. No.99-4649.
3. Metzger ML, Dome JS. Current therapy for Wilms' tumor. Oncologist. 2005;10:815-826.
4. Grovas A, Fremgen A, Rauck A, et al. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer. 1997;80:2321-2332.
5. Wu HY, Snyder HM III, D'Angio GJ. Wilms' tumor management. Curr Opin Urol. 2005;15:273-276.
6. Shamberger RC, Guthrie KA, Ritchey ML, et al. Surgery-related factors and local recurrence of Wilms tumor in National Wilms tumor study 4. Ann Surg. 1999;229:292-297.
7. Ehrlich PF, Ritchey ML, Hamilton TE, et al. Quality assessment for Wilms' tumor: a report from the National Wilms' tumor study-5. J Pediatr Surg. 2005;40:208-212; discussion 212-213.
8. Kim S, Chung DH. Pediatric solid malignancies: neuroblastoma and Wilms' tumor. Surg Clin North Am. 2006;86:469-487, xi.
9. Dome JS, Liu T, Krasin M, et al. Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital. J Pediatr Hematol Oncol. 2002;24:192-198.
10. Miser JS, Tournade MF. The management of relapsed Wilms tumor. Hematol Oncol Clin North Am. 1995;9:1287-1302.
11. Breslow N, Churchill G, Beckwith JB, et al. Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis-results of the second National Wilms' tumor study. J Clin Oncol. 1985;3:521-531.
12. D'Angio GJ, Evans AE, Breslow N, et al. The treatment of Wilms' tumor: results of the national Wilms' tumor study. Cancer. 1976;38:633-646.
13. Jereb B, Tournade MF, Lemerle J, et al. Lymph node invasion and prognosis in nephroblastoma. Cancer. 1980;45:1632-1636.
14. Othersen HB Jr, DeLorimer A, Hrabovsky E, et al. Surgical evaluation of lymph node metastases in Wilms' tumor. J Pediatr Surg. 1990;25:330-331.
15. D'Angio GJ, Evans A, Breslow N, et al. The treatment of Wilms' tumor: results of the Second National Wilms' tumor study. Cancer. 1981;47:2302-2311.
16. Exelby PR. The objectives and importance of operative staging of children with cancer. Cancer. 1986;58(suppl 2):421-425.
17. Neville HL, Ritchey ML. Wilms' tumor. Overview of National Wilms' tumor study group results. Urol Clin North Am. 2000;27:435-442.
18. National Cancer Data Base. 2008. Available at: www.facs.org/cancer/ncdb.
19. Commission on Cancer: Approval Categories. 2008. Available at: www. facs.org/cancer/coc/categories.html. Accessed August 30, 2005.
20. Winchester DP, Stewart AK, Bura C, et al. The National Cancer data base: a clinical surveillance and quality improvement tool. J Surg Oncol. 2004;85: 1-3.
21. Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer data base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683-690.
22. Lange JR, Palis BE, Chang DC, et al. Melanoma in children and teenagers: an analysis of patients from the National Cancer data base. J Clin Oncol. 2007;25:1363-1368.
23. Childrens Oncology Group Cure Search. 2009. Available at: http://www. childrensoncologygroup.org/. Accessed January 19, 2009.
24. National Cancer Institute: SEER Surveillance Epidemiology and End Results. Available at: www.seer.cancer.gov. Accessed 2008.
25. National Program of Cancer Registries (NPCR): Cancer Surveillance System Rationale and Approach. Available at: www.cdc.gov/cancer/nrcr/training/ css.htm. Accessed 2008.
26. National Cancer Registrars Association: Certification. Available at: www. ncra-usa.org/certification/index.htm. Accessed 2008.
27. Standards for Cancer Registries. Data Standards and Data Dictionary. Vol II. Springfield, IL: North American Association of Central Cancer Registries; 2003.
28. World Health Organization. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
29. Commission on Cancer, American College of Surgeons. FORDS: Facility Oncology Registry Data Standards-Revised for 2007. Chicago, IL: Commission on Cancer, American College of Surgeons 2007.
30. Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
31. Cox D. Regression models and life tables. J R Stat Soc. 1972;34:187-220.
32. Shochat SJ. Wilms' tumor: diagnosis and treatment in the 1990s. Semin Pediatr Surg. 1993;2:59-68.
33. Green DM, Beckwith JB, Breslow NE, et al. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 1994;12:2126-2131.
34. Ehrlich PF. Wilms tumor: progress and considerations for the surgeon. Surg Oncol. 2007;16:157-171.
35. Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
36. Bilimoria KY, Stewart AK, Palis BE, et al. Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg. 2008;206:247-254.
37. Tomlinson JS, Jain S, Bentrem DJ, et al. Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg. 2007;142:767-723; discussion 773-774.
38. Neglia JP, Nesbit ME Jr. Care and treatment of long-term survivors of childhood cancer. Cancer. 1993;71(suppl 10):3386-3391.
39. Wright JL, Lin DW, Porter MP. The association between extent of lymph-adenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer. 2008;112:2401-2408.
40. Fuchs J, Kienecker K, Furtwangler R, et al. Surgical aspects in the treatment of patients with unilateral Wilms tumor: a report from the SIOP 93-01/ German Society of Pediatric Oncology and Hematology. Ann Surg. 2009; 249:666-671.
41. Perlman EJ. Pediatric renal tumors: practical updates for the pathologist. Pediatr Dev Pathol. 2005;8:320-338.
42. Vujanic GM, Sandstedt B, Kelsey A, et al. Central pathology review in multicenter trials and studies: lessons from the nephroblastoma trials. Cancer. 2009;115:1977-1983.
43. Dome JS, Cotton CA, Perlman EJ, et al. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study. J Clin Oncol. 2006;24:2352-2358.